Improving care for patients with Staphylococcus aureus bacteremia through phone consultations
SAB-Support-Study: Can Checklist-based Phone Calls Improve the Quality of Staphylococcus Aureus Bacteraemia (SAB) Management
NA · University Medicine Greifswald · NCT06249451
This study is testing whether phone consultations can help patients with Staphylococcus aureus bacteremia follow treatment guidelines better and improve their care.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 124 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Medicine Greifswald (other) |
| Locations | 1 site (Greifswald) |
| Trial ID | NCT06249451 on ClinicalTrials.gov |
What this trial studies
This study aims to enhance adherence to established guidelines for managing Staphylococcus aureus bacteremia (SAB) by implementing a checklist-based telephone consultation system. The approach involves close monitoring and support for patients diagnosed with SAB during their hospital stay. The study will evaluate the impact of these consultations on clinical outcomes and overall patient care. By focusing on quality improvement, the research seeks to establish effective strategies for managing this serious infection.
Who should consider this trial
Good fit: Ideal candidates for this study are adult inpatients at the University Medicine Greifswald who are receiving their first diagnosis of SAB during hospitalization.
Not a fit: Patients who have a prior diagnosis of SAB before admission or those who are receiving palliative care may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to better management of Staphylococcus aureus bacteremia, improving patient outcomes and adherence to treatment guidelines.
How similar studies have performed: While this specific approach is novel, similar studies focusing on guideline adherence and quality improvement in infectious disease management have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ≥ 18 years * Inpatient treatment at the University Medicine Greifswald university hospital * First diagnosis of SAB in hospital Exclusion Criteria: * SAB already known before admission * Palliative management within 48 hrs after SAB diagnosis * Death within 48 hrs after SAB diagnosis * Hospital discharge within 48hrs after SAB diagnosis
Where this trial is running
Greifswald
- Greifswald University Medicine — Greifswald, Germany (RECRUITING)
Study contacts
- Study coordinator: Lena Ulm
- Email: lena.ulm@med.uni-greifswald.de
- Phone: 00493834865569
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Staphylococcus Aureus Bacteremia, Staphylococcus aureus, Bacteremia